Related references
Note: Only part of the references are listed.Blocking Aerobic Glycolysis by Targeting Pyruvate Dehydrogenase Kinase in Combination with EGFR TKI and Ionizing Radiation Increases Therapeutic Effect in Non-Small Cell Lung Cancer Cells
Sissel E. Dyrstad et al.
CANCERS (2021)
Recent Advances in the Rational Drug Design Based on Multi-target Ligands
Ting Yang et al.
CURRENT MEDICINAL CHEMISTRY (2020)
ff19SB: Amino-Acid-Specific Protein Backbone Parameters Trained against Quantum Mechanics Energy Surfaces in Solution
Chuan Tian et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2020)
Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activities
Shanshan Lin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Design of Dual Inhibitors of Histone Deacetylase 6 and Heat Shock Protein 90
Luca Pinzi et al.
ACS OMEGA (2020)
Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations
Samuele Maramai et al.
BIOMED RESEARCH INTERNATIONAL (2020)
A fast and high-quality charge model for the next generation general AMBER force field
Xibing He et al.
JOURNAL OF CHEMICAL PHYSICS (2020)
Novel Multitarget Therapies for Lung Cancer and Respiratory Disease
Masako Yumura et al.
MOLECULES (2020)
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds
Ewgenij Proschak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Harnessing Polypharmacology with Medicinal Chemistry
Maria Laura Bolognesi
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Combination therapies with HSP90 inhibitors against colorectal cancer
Kushtrim Kryeziu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Molecular Docking: Shifting Paradigms in Drug Discovery
Luca Pinzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Design and synthesis of triple inhibitors of janus kinase (JAK), histone deacetylase (HDAC) and Heat Shock Protein 90 (HSP90)
Lianbin Yao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall
Alessandro Leonetti et al.
CANCER TREATMENT REVIEWS (2018)
CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds
Alexey A. Lagunin et al.
PLOS ONE (2018)
Synthesis and Biological Evaluation of Migrastatin Macrotriazoles
Adele Gabba et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2017)
Heat shock protein 90 and serine/threonine kinase B-Raf inhibitors have overlapping chemical space
A. Anighoro et al.
RSC ADVANCES (2017)
The 1,2,3-triazole ring as a bioisostere in medicinal chemistry
Elisa Bonandi et al.
DRUG DISCOVERY TODAY (2017)
Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling
Longbin Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Gao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
Wen Zhang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2015)
Computational Polypharmacology Analysis of the Heat Shock Protein 90 Interactome
Andrew Anighoro et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Computational polypharmacology comes of age
Giulio Rastelli et al.
FRONTIERS IN PHARMACOLOGY (2015)
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma Cells
Rikio Suzuki et al.
PLOS ONE (2015)
Synthesis and Evaluation of New Hsp90 Inhibitors Based on a 1,4,5-Trisubstituted 1,2,3-Triazole Scaffold
Maurizio Taddei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Discovery and Optimization of 4,5-Diarylisoxazoles as Potent Dual Inhibitors of Pyruvate Dehydrogenase Kinase and Heat Shock Protein 90
Tao Meng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Polypharmacology: Challenges and Opportunities in Drug Discovery
Andrew Anighoro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Overcoming Acquired BRAF Inhibitor Resistance in Melanoma via Targeted Inhibition of Hsp90 with Ganetespib
Jaime Acquaviva et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Polypharmacology - Foe or Friend?
Jens-Uwe Peters
JOURNAL OF MEDICINAL CHEMISTRY (2013)
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Joanna Kaplon et al.
NATURE (2013)
Structure, Function and Regulation of the Hsp90 Machinery
Johannes Buchner et al.
Biomedical Journal (2013)
'Click' synthesis of a triazole-based inhibitor of Met functions in cancer cells
Francesco Colombo et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?
Len Neckers et al.
CLINICAL CANCER RESEARCH (2012)
Potent and Selective Aminopyrimidine-Based B-Raf Inhibitors with Favorable Physicochemical and Pharmacokinetic Properties
Simon Mathieu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Fragment Screening Using Capillary Electrophoresis (CEfrag) for Hit Identification of Heat Shock Protein 90 ATPase Inhibitors
Carol Austin et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Pyrazolopyridine inhibitors of B-RafV600E. Part 2: Structure-activity relationships
Steve Wenglowsky et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity
Theonie Anastassiadis et al.
NATURE BIOTECHNOLOGY (2011)
Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution
Jeremy R. Greenwood et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2010)
Structure-Based and in silico Design of Hsp90 Inhibitors
Miriam Sgobba et al.
CHEMMEDCHEM (2009)
Potent and selective pyrazole-based inhibitors of B-Raf kinase
Joshua D. Hansen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer
Paul A. Brough et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
James Tsai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol
Masato Kato et al.
STRUCTURE (2007)
A study of the scope and regioselectivity of the ruthenium-catalyzed [3+2]-cycloaddition of azides with internal alkynes
Max M. Majireck et al.
JOURNAL OF ORGANIC CHEMISTRY (2006)
A fluorescence polarization assay for inhibitors of Hsp90
R Howes et al.
ANALYTICAL BIOCHEMISTRY (2006)
Novel procedure for modeling ligand/receptor induced fit effects
W Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
V600E B-Raf requires the Hsp90 chaperone for stability and is degraded in response to Hsp90 inhibitors
OM Grbovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Share Paper
